SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2013 / Cilt: 22 - Sayı: 3

FDG PET/BT’nin Böbrek Metastazlarını Değerlendirmedeki Değeri Hafife mi Alınıyor? Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Is The Value of FDG PET/CT In Evaluating Renal Metastasis Underestimated? A Case Report And Review of The Literature

Mustafa ARAS
FUAT DEDE
TUNÇ ÖNEŞ
SABAHAT İNANIR
TANJU YUSUF ERDİL
Halil Turgut TUROĞLU
Pages
109–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses.
📊
Key Findings & Data:On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract.
💡
Conclusion & Impact:We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses. On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract. We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study

Özet

Kontrastlı BT ve MR renal kitlelerin saptanması ve tanımlanmasında altın standart olarak kullanılan görüntüleme yöntemleridir. Diğer taraftan, F-18 FDG’nin üriner sistem yoluyla atılması, F-18 FDG PET/BT’nin böbreğin primer ve metastatik tümörlerini değerlendirmedeki rolünü belirgin kısıtlamıştır. Bu olgu sunumunda, daha önceki PET/BT ve tanısal abdominal BT incelemelerinde gözden kaçan ancak takip PET/BT’de her iki böbrekte çoklu metastazları saptanan akciğer kanserli bir olgu sunuldu.

🔖

Cite This Article

ARAS, M., DEDE, F., ÖNEŞ, T., İNANIR, S., ERDİL, T. Y., TUROĞLU, H. T. (2013). FDG PET/BT’nin Böbrek Metastazlarını Değerlendirmedeki Değeri Hafife mi Alınıyor? Olgu Sunumu ve Literatürün Gözden Geçirilmesi. Molecular Imaging and Radionuclide Therapy, Cilt: 22 - Sayı: 3, 109–112. https://ajindex.com/articles/295222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Olsson CA, Moyer JD, Laferte RO. Pulmonary cancer metastatic to the kidney-a common renal neoplasm. J Urol 1971;105:492-496
  2. Lockhart ME, Smith KJ, Kenney PJ. The Kidney and Ureter. In: Lee JKT, Sagel SS, Stanley RJ (eds). Computed Body Tomography with MRI Correlation. Philadelphia Lippincott Williams & Wilkins; 2006;1233-1310
  3. Prasad SR, Dalrymple NC, Surabhi VR. Cross-sectional imaging evaluation of renal masses. Radiol Clin North Am 2008;46:95-111
  4. Bailey JE, Roubidoux MA, Dunnick NR. Secondary renal neoplasms. Abdom Imaging 1998;23:266-274
  5. Yagcı C, Ozcan H. Radiological diagnosis of renal tumors. Turkiye Klinikleri J Med Sci 1995;15:225-233
  6. Karalar M, Ateş M. Other malign renal tumors. Turkiye Klinikleri J Urology-Special Topics 2011;4:87-90
  7. Patel U, Ramachandran N, Halls J, Parthipun A, Slide C. Synchronous renal masses in patients with a nonrenal malignancy: incidence of metastasis to the kidney versus primary renal neoplasia and differentiating features on CT. AJR Am J Roentgenol 2011;197:680- 686
  8. Becker WE, Schellhammer PF. Renal metastases from carcinoma of the lung. Br J Urol 1986;58:494-498
  9. Bach AM, Zhang J. Contemporary radiologic imaging of renal cortical tumors. Urol Clin North Am 2008;35:593-604
  10. Miller JC, Samir A, McGovern FJ, Thrall JH, Lee SI. Evaluation of renal masses. J Am Coll Radiol 2008;5:857-860
  11. Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. Radiographics 2008;28:1325-1238
  12. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004;171:1806-12809
  13. Lin EC, Alavi A. Urologic Tumors. In: Lin EC, Alavi A (eds). PET and PET/CT: A clinical guide. New York Thieme; 2009;204-211
  14. Goldberg MA, Mayo-Smith WW, Papanicolaou N, Fischman AJ, Lee MJ. FDG PET characterization of renal masses: preliminary experience. Clin Radiol 1997;52:510-515.